Chennai, India (CU)_ IBA (Ion Beam Applications S.A., EURONEXT), a global pioneer in particle accelerator technology and a market leader in providing proton therapy solutions for the deadly cancer therapy, has entered into a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL) to offer proton therapy training and education programs to Asian IBA customers.
AEHL is an old and loyal customer of IBA, having acquired a ProteusPLUS[1] proton therapy system in 2013 and using it effectively to treat cancer patients for over three years. Since AHEL began the proton therapy process at Apollo Proton Cancer Centers (APCC), it has amassed extensive…
